Stock comparison
10x Genomics
TXG$3.01BHealthcare Market cap, Sector
United Therapeutics
UTHR$24.13BHealthcare Market cap, Sector
Overall winner
United Therapeutics
TXG 07 UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
TXG0wins
7winsUTHR
33F
B71
54D
B76
34F
B76
15F
C62
0F
D46
29F
C64
31F
C64
Side-by-side metrics
| Metric | TXG | UTHR |
|---|---|---|
| Market cap | $3.01B | $24.13B Winner |
| P/E (TTM) | Winner: - | 19.2x |
| EV/EBIT | Winner: - | 15.2x |
| ROIC (TTM) | -4.24% | 18.81% Winner |
| Gross margin | 69.6% | 86.58% Winner |
| Net margin | -3.55% | 40.61% Winner |
| Revenue CAGR 5y | 7.0% | 17.22% Winner |
| EPS CAGR 5y | - | 29.84% |
| Debt / Equity | 0.1x | - Winner |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
TXG leads on
- EV/EBIT-vs 15.2x+173%
- P/E (TTM)-vs 19.2x+116%
UTHR leads on
- ROIC (TTM)18.81%vs -4.24%+123%
- Net margin40.61%vs -3.55%+109%
- Debt / Equity-vs 0.1x+100%
- Market cap$24.13Bvs $3.01B+88%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.